SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-795948
Filing Date
2016-12-16
Accepted
2016-12-16 17:24:31
Documents
4
Period of Report
2016-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d283294d8k.htm 8-K 21060
2 EX-10.1 d283294dex101.htm EX-10.1 215100
3 EX-99.1 d283294dex991.htm EX-99.1 19830
4 GRAPHIC g283294logo1.jpg GRAPHIC 37968
  Complete submission text file 0001193125-16-795948.txt   309598
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 162057181
SIC: 2836 Biological Products, (No Diagnostic Substances)